LEUKODYSTROPHY, HYPOMYELINATING, 12
|
0.700 |
Biomarker
|
disease |
GENOMICS_ENGLAND |
A Founder Mutation in VPS11 Causes an Autosomal Recessive Leukoencephalopathy Linked to Autophagic Defects.
|
27120463 |
2016 |
LEUKODYSTROPHY, HYPOMYELINATING, 12
|
0.700 |
Biomarker
|
disease |
GENOMICS_ENGLAND |
A Founder Mutation in VPS11 Causes an Autosomal Recessive Leukoencephalopathy Linked to Autophagic Defects.
|
27120463 |
2016 |
LEUKODYSTROPHY, HYPOMYELINATING, 12
|
0.700 |
GermlineCausalMutation
|
disease |
ORPHANET |
Hypomyelination and developmental delay associated with VPS11 mutation in Ashkenazi-Jewish patients.
|
26307567 |
2015 |
LEUKODYSTROPHY, HYPOMYELINATING, 12
|
0.700 |
GeneticVariation
|
disease |
UNIPROT |
Hypomyelination and developmental delay associated with VPS11 mutation in Ashkenazi-Jewish patients.
|
26307567 |
2015 |
LEUKODYSTROPHY, HYPOMYELINATING, 12
|
0.700 |
Biomarker
|
disease |
GENOMICS_ENGLAND |
Hypomyelination and developmental delay associated with VPS11 mutation in Ashkenazi-Jewish patients.
|
26307567 |
2015 |
LEUKODYSTROPHY, HYPOMYELINATING, 12
|
0.700 |
Biomarker
|
disease |
CTD_human |
|
|
|
LEUKODYSTROPHY, HYPOMYELINATING, 12
|
0.700 |
CausalMutation
|
disease |
CLINVAR |
|
|
|
Leukoencephalopathy
|
0.110 |
GeneticVariation
|
group |
BEFREE |
Using whole exome sequencing (WES), we identified homozygosity for a missense variant, VPS11: c.2536T>G (p.C846G), as the genetic cause of a leukoencephalopathy syndrome in five individuals from three unrelated Ashkenazi Jewish (AJ) families.
|
27120463 |
2016 |
Global developmental delay
|
0.110 |
GeneticVariation
|
disease |
BEFREE |
Hypomyelination and developmental delay associated with VPS11 mutation in Ashkenazi-Jewish patients.
|
26307567 |
2015 |
Leukoencephalopathy
|
0.110 |
CausalMutation
|
group |
CLINVAR |
|
|
|
Global developmental delay
|
0.110 |
Biomarker
|
disease |
HPO |
|
|
|
Waist-Hip Ratio
|
0.100 |
GeneticVariation
|
phenotype |
GWASCAT |
Meta-analysis of genome-wide association studies for body fat distribution in 694 649 individuals of European ancestry.
|
30239722 |
2019 |
Body mass index
|
0.100 |
GeneticVariation
|
phenotype |
GWASCAT |
Leveraging Polygenic Functional Enrichment to Improve GWAS Power.
|
30595370 |
2019 |
Body mass index
|
0.100 |
GeneticVariation
|
phenotype |
GWASCAT |
Meta-analysis of genome-wide association studies for body fat distribution in 694 649 individuals of European ancestry.
|
30239722 |
2019 |
Body mass index
|
0.100 |
GeneticVariation
|
phenotype |
GWASCAT |
Protein-altering variants associated with body mass index implicate pathways that control energy intake and expenditure in obesity.
|
29273807 |
2018 |
Coronary Artery Disease
|
0.100 |
GeneticVariation
|
disease |
GWASCAT |
Identification of 64 Novel Genetic Loci Provides an Expanded View on the Genetic Architecture of Coronary Artery Disease.
|
29212778 |
2018 |
High density lipoprotein measurement
|
0.100 |
GeneticVariation
|
phenotype |
GWASDB |
Large-scale gene-centric meta-analysis across 32 studies identifies multiple lipid loci.
|
23063622 |
2012 |
Serum HDL cholesterol measurement
|
0.100 |
GeneticVariation
|
phenotype |
GWASDB |
Large-scale gene-centric meta-analysis across 32 studies identifies multiple lipid loci.
|
23063622 |
2012 |
Neurogenic Urinary Bladder
|
0.100 |
Biomarker
|
disease |
HPO |
|
|
|
Neurogenic Urinary Bladder
|
0.100 |
CausalMutation
|
disease |
CLINVAR |
|
|
|
Borderline intellectual disability
|
0.100 |
CausalMutation
|
disease |
CLINVAR |
|
|
|
Constipation
|
0.100 |
Biomarker
|
phenotype |
HPO |
|
|
|
Febrile Convulsions
|
0.100 |
CausalMutation
|
disease |
CLINVAR |
|
|
|
Febrile Convulsions
|
0.100 |
Biomarker
|
disease |
HPO |
|
|
|
Deglutition Disorders
|
0.100 |
CausalMutation
|
group |
CLINVAR |
|
|
|